PMA

P980024: PATHVYSION HER-2 DNA PROBE KIT

FDA PMA · System, Test, Her-2/Neu, Nucleic Acid Or Serum · Abbott Molecular, Inc.

Key facts

PMA number P980024
Trade name PATHVYSION HER-2 DNA PROBE KIT
Generic name System, Test, Her-2/Neu, Nucleic Acid Or Serum
Applicant Abbott Molecular, Inc.
Owner/operator ABBOTT LABORATORIES
Product code MVD
Approval date Dec 11, 1998
Docket number 99M-0034
Notice date Jan 20, 1999
Establishment registration 3005248192
FEI number 3005248192

At a glance

  • 10–99 Supplements
  • Mar 18, 2022 Latest supplement decision
  • No Withdrawn
  • No Summary of safety and effectiveness on file
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals